Product Program year 2025 Source: CMS Open Payments

Margenza

Drug Oncology

NDC 70720-022-02

Open in the dashboard

General payments

$17,936

31 payments

Research payments

$496,212

1 payment

Through program year 2025, $17,936 in general payments and $496,212 in research payments were reported against Margenza (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $17,936 31
2025 Research $496,212 1

Breakdown

Who paid General payments · program year 2025
  1. TerSera Therapeutics LLC $17,936 31 payments
Top recipients General payments · program year 2025
  1. Mark Pegram Medical Oncology · Stanford, CA $3,841 21% · 4 payments
  2. Eleni Andreopoulou Hematology & Oncology · Houston, TX $2,205 12% · 6 payments
  3. Vijayakrishna Gadi Medical Oncology · Seattle, WA $1,572 9% · 3 payments
  4. Don Dizon Medical Oncology · Providence, RI $1,500 8% · 1 payment
  5. Seth Wander Hematology & Oncology · Boston, MA $1,500 8% · 1 payment

The top 5 of 17 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Medical Oncology Internal Medicine $9,258 52% · 6 practitioners
  2. Hematology & Oncology Internal Medicine $7,306 41% · 8 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $599 3% · 1 practitioner
  4. Ophthalmology $513 3% · 1 practitioner
  5. Gynecologic Oncology Obstetrics & Gynecology $260 1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Massachusetts $5,319 30% · 5 recipients
  2. California $4,614 26% · 3 recipients
  3. New York $4,434 25% · 5 recipients
  4. Illinois $1,814 10% · 2 recipients
  5. Florida $1,369 8% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

31 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record